Pharsight

AMGEN EUROPE GMBH PATENTS FACING OPPOSITIONS

Top patents of AMGEN EUROPE GMBH facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2797581B1 06 May, 2020 Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione Dec, 2032 3
EP3320902B1 17 Feb, 2021 Methods For Treating Diseases Using Isoindoline Compounds Mar, 2032 1